Impel Pharmaceuticals is a company that focuses on developing and providing transformative therapies for people suffering from diseases with high unmet medical needs through the pioneering of an optimized approach to drug delivery. They are the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and formulations, which have the potential to improve the onset of symptomatic relief for a spectrum of conditions.
Location: United States, Washington, Seattle
Employees: 51-200
Founded date: 2008
Investors 2
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
| 04.03.2023 | Kohlberg K... | kkr.com |
Mentions in press and media 1
| Date | Title | Description |
| 05.05.2023 | Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 | SEATTLE, May 05, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. IMPL, a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it wi... |